Vaginal Estrogen With Pessary Treatment
Use of Vaginal Estrogen With Pessary Treatment of Pelvic Organ Prolapse and Urinary Incontinence
Sponsor: Academic Medical Organization of Southwestern Ontario
Listed as NCT01843166, this NA trial focuses on Quality of Life and Urinary Tract Infection and remains completed. Sponsored by Academic Medical Organization of Southwestern Ontario, it has been updated 8 times since 2012, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Apr 2025 — Present [monthly]
Completed NA
-
Jan 2025 — Apr 2025 [monthly]
Completed NA
-
Sep 2024 — Jan 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Dec 2018 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jun 2018 — Dec 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Academic Medical Organization of Southwestern Ontario
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- University of Western Ontario, Canada
For direct contact, visit the study record on ClinicalTrials.gov .